Sanofi, Evotec to accelerate infectious disease R&D with new open innovation platform
Evotec and Sanofi have entered exclusive talks to create an Evotec-led Infectious Disease open innovation R&D platform, the companies said…
Pharmaceuticals, Biotechnology and Life Sciences
Evotec and Sanofi have entered exclusive talks to create an Evotec-led Infectious Disease open innovation R&D platform, the companies said…
BASF is in exclusive talks to acquire Bayer’s entire vegetable seeds business, operating under the global trademark Nunhems, said BASF…
As personalised medicines become more and more prominent in today’s industry, Professor Phillipe Arnaud – Chief of Pharmacy Department at…
Novartis aims to initiate up to 10 new clinical trials over the next three year with a leader in decentralized clinical trial…
Sonoma Pharmaceuticals got near $4.6 million from an offering of 1,428,570 shares for price of $3.50 per share, after deducting…
Amryt has expanded its market coverage for Lojuxta with an exclusive distribution agreement for Lebanon, Jordan and Syria, as it…
Pfizer has appointed a professor of molecular immunology Dr. Dan R. Littman to its Board of Directors, was also appointed…
ProMIS Neurosciences’s lead product candidate for Alzheimer’s disease, PMN310, showed similar ability to cross the blood brain barrier and penetrate…
Novartis’ Xolair has been recommended in new global chronic urticaria guideline, the company noted Tuesday, as add-on therapy for the…
Grupo Biotoscana has launched Basilea’s hospital antibiotic Zevtera (ceftobiprole) in Argentina, Basilea Pharmaceutica said Tuesday.